DE69601765T2 - Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten - Google Patents

Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten

Info

Publication number
DE69601765T2
DE69601765T2 DE69601765T DE69601765T DE69601765T2 DE 69601765 T2 DE69601765 T2 DE 69601765T2 DE 69601765 T DE69601765 T DE 69601765T DE 69601765 T DE69601765 T DE 69601765T DE 69601765 T2 DE69601765 T2 DE 69601765T2
Authority
DE
Germany
Prior art keywords
compositions containing
iridaceae
extract
iridaceae extract
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69601765T
Other languages
English (en)
Other versions
DE69601765D1 (de
Inventor
Lionel Breton
Richard Martin
Lacharriere Olivier De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510487A external-priority patent/FR2738488B1/fr
Priority claimed from FR9510486A external-priority patent/FR2738486B1/fr
Priority claimed from FR9603815A external-priority patent/FR2746647B1/fr
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69601765D1 publication Critical patent/DE69601765D1/de
Application granted granted Critical
Publication of DE69601765T2 publication Critical patent/DE69601765T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
DE69601765T 1995-09-07 1996-08-13 Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten Expired - Lifetime DE69601765T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510487A FR2738488B1 (fr) 1995-09-07 1995-09-07 Composition contenant a titre de principe actif au moins un extrait d'au moins une iridacee
FR9510486A FR2738486B1 (fr) 1995-09-07 1995-09-07 Utilisation d'au moins un extrait d'au moins une iridacee dans une composition cosmetique ou pharmaceutique
FR9603815A FR2746647B1 (fr) 1996-03-27 1996-03-27 Composition apaisante comprenant un extrait d'iridacee

Publications (2)

Publication Number Publication Date
DE69601765D1 DE69601765D1 (de) 1999-04-22
DE69601765T2 true DE69601765T2 (de) 1999-07-08

Family

ID=27253096

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69601765T Expired - Lifetime DE69601765T2 (de) 1995-09-07 1996-08-13 Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten

Country Status (12)

Country Link
US (1) US6471997B1 (de)
EP (1) EP0765668B1 (de)
JP (1) JP3093154B2 (de)
AR (1) AR003496A1 (de)
BR (1) BR9610375A (de)
CA (1) CA2185037C (de)
DE (1) DE69601765T2 (de)
ES (1) ES2132855T3 (de)
MX (1) MX9710479A (de)
PL (1) PL186769B1 (de)
RU (1) RU2169000C2 (de)
WO (1) WO1997009056A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937304A1 (de) * 1999-08-10 2001-03-15 Boehringer Ingelheim Pharma Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746641B1 (fr) * 1996-03-27 1998-06-05 Oreal Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
JPH11269066A (ja) * 1998-03-20 1999-10-05 Kao Corp 経口用美白剤及び美白用食品
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
FR2795637A1 (fr) 1999-07-02 2001-01-05 Oreal Utilisation de cellules vegetales dedifferenciees
FR2811893B1 (fr) * 2000-07-18 2003-04-18 Oreal Utilisation d'au moins un extrait d'au moins une iridacee dans une composition destinee a stimuler defenses immunitaires
JP4698810B2 (ja) * 2000-10-13 2011-06-08 日本メナード化粧品株式会社 皮膚外用剤
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
DE10111054A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
DE10111052A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10111049A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
DE10146159A1 (de) 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
RU2201255C1 (ru) * 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
BRPI0410913A (pt) * 2003-06-05 2006-06-27 Warner Lambert Co benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
JP2006526608A (ja) * 2003-06-05 2006-11-24 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー Ｐｉ３ｋ活性を有する治療薬としてのテトラゾールベンゾフランカルボキシアミド
MXPA05012953A (es) * 2003-06-05 2006-02-13 Warner Lambert Co Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
CA2527779A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-substituted indoles and derivatives thereof as therapeutic agents
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
MXPA05013210A (es) * 2003-06-05 2006-03-09 Warner Lambert Co Benzo[b]tiofenos cicloalquilsulfanil-sustituidos como agentes terapeuticos.
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
FR2916351B1 (fr) 2007-05-22 2012-12-07 Galderma Res & Dev Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique
WO2011155542A1 (ja) * 2010-06-09 2011-12-15 花王株式会社 水蒸気発生温熱具
DE112011102358T5 (de) 2010-07-15 2013-04-25 Oleg Iliich Epshtein Verfahren zur Erhöhung der Wirkung einer aktivierten-potenzierten Form eines Antikörpers
FR2970868B1 (fr) * 2011-01-31 2023-10-27 Sederma Sa Extrait d'origine vegetale, composition le contenant, procede d'obtention par culture vegetale et utilisations dans les domaines cosmetique, pharmaceutique et cosmeceutique
JP5913138B2 (ja) * 2011-02-01 2016-04-27 株式会社林原 皮膚外用剤
JP5923375B2 (ja) 2012-04-24 2016-05-24 花王株式会社 Ｃｇｒｐ応答性促進剤
FR3001391B1 (fr) * 2013-01-29 2017-07-07 Oreal Utilisation de cellules vegetales d'iridacee elicitees dans le traitement des peaux sensibles
JP6317993B2 (ja) * 2014-05-07 2018-04-25 ポーラ化成工業株式会社 肌改善剤のスクリーニング方法
US20200164014A1 (en) * 2017-07-18 2020-05-28 Shiseido Company, Ltd. Mesenchymal stem cell attracting agent
CN112956733B (zh) * 2021-02-07 2023-06-20 无锡华叶生物科技有限公司 一种烟用鸢尾根分离物的制备方法
CN114409544B (zh) * 2022-01-30 2023-06-13 西安交通大学 具有血管舒张活性的苯丙素及其提取方法和应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261924A (ja) * 1985-09-11 1987-03-18 Shiseido Co Ltd 皮膚外用剤
JPS62289509A (ja) * 1986-06-10 1987-12-16 Shiseido Co Ltd 頭髪化粧料
JPS63196522A (ja) * 1987-02-10 1988-08-15 Zeria Shinyaku Kogyo Kk 抗消化性潰瘍剤
JPS63216824A (ja) * 1987-03-05 1988-09-09 Zeria Shinyaku Kogyo Kk 抗消化性潰瘍剤
US4963480A (en) 1988-08-05 1990-10-16 Roure S.A. Process for the preparation of gamma-irone
JPH02142743A (ja) * 1988-11-22 1990-05-31 Zeria Pharmaceut Co Ltd テルペン化合物及び該化合物を含有する抗消化性潰瘍剤
JPH02163017A (ja) * 1988-12-13 1990-06-22 Shiseido Co Ltd イリス属植物の組織培養方法
JP3314785B2 (ja) * 1990-09-28 2002-08-12 大正製薬株式会社 ミノキシジル含有育毛剤
JPH04182446A (ja) * 1990-11-15 1992-06-30 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
CH683594A5 (de) * 1991-01-24 1994-04-15 Flachsmann Ag Emil Verfahren zur Herstellung eines Pflanzenextrakt enthaltenden Masse, welche insbesondere für die Einkapselung in ein festes Umhüllungsmaterial geeignet ist.
JP2955055B2 (ja) * 1991-03-30 1999-10-04 鐘紡株式会社 養毛化粧料
JP3607709B2 (ja) * 1991-04-02 2005-01-05 大正製薬株式会社 皮膚外用保湿剤
JPH05221915A (ja) * 1992-02-14 1993-08-31 Mitsubishi Kasei Corp １，４−ベンゾキノン誘導体
JPH06327484A (ja) * 1993-05-21 1994-11-29 Shiseido Co Ltd イロン類の製造方法
JP3605420B2 (ja) * 1993-07-14 2004-12-22 三省製薬株式会社 皮膚外用剤
EP0716661B1 (de) * 1993-09-09 2000-04-05 Scios Inc. Pseudo-oder nicht peptidartige bradykinin rezeptor antagoniste
JP3501832B2 (ja) * 1993-11-15 2004-03-02 一丸ファルコス株式会社 ヒオウギ抽出物を含有するテストステロン５α−リダクターゼ阻害剤とその応用
US5364881A (en) * 1993-11-15 1994-11-15 The Medical College Of Wisconsin Research Foundation, Inc. S-alkyl-isothioureido-amino acids and use thereof
JP3294694B2 (ja) * 1993-11-15 2002-06-24 一丸ファルコス株式会社 ヒオウギ抽出物を含有する細胞賦活剤とその応用
JP3078694B2 (ja) * 1993-12-17 2000-08-21 キッコーマン株式会社 ゲニステインの製造法
JPH07285845A (ja) * 1994-04-19 1995-10-31 Pola Chem Ind Inc 皮膚化粧料
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
US5550132A (en) * 1994-06-22 1996-08-27 University Of North Carolina Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
JP3803398B2 (ja) * 1994-08-01 2006-08-02 ポーラ化成工業株式会社 人体過剰対応抑制剤
JP3769036B2 (ja) * 1994-08-01 2006-04-19 ポーラ化成工業株式会社 人体過剰対応抑制剤
JPH0859536A (ja) * 1994-08-12 1996-03-05 Shiseido Co Ltd 新規トリテルペノイド類
AU4264396A (en) * 1994-11-25 1996-06-19 Laboratoires De Biologie Vegetale Yves Rocher Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
US6455076B1 (en) 1994-12-21 2002-09-24 Gary S. Hahn Formulations and methods for reducing skin irritation
CA2208268A1 (en) 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
US5716625A (en) 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2729855A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
JPH08301758A (ja) * 1995-04-28 1996-11-19 Shiseido Co Ltd 皮膚外用剤
JP3481386B2 (ja) * 1995-05-17 2003-12-22 株式会社資生堂 美白用皮膚外用剤
PL186017B1 (pl) * 1995-09-07 2003-09-30 Oreal Zastosowanie ekstraktu z niefotosyntetyzującej bakterii nitkowatej oraz kompozycja zawierająca takiekstrakt
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
FR2772610B1 (fr) * 1997-12-19 2006-06-02 Oreal Utilisation de l'acide cinnamique ou d'au moins l'un de ses derives dans une composition cosmetique
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937304A1 (de) * 1999-08-10 2001-03-15 Boehringer Ingelheim Pharma Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen
DE19937304C2 (de) * 1999-08-10 2003-08-21 Boehringer Ingelheim Pharma Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen

Also Published As

Publication number Publication date
CA2185037C (fr) 2007-06-26
BR9610375A (pt) 1999-07-06
WO1997009056A1 (fr) 1997-03-13
DE69601765D1 (de) 1999-04-22
PL186769B1 (pl) 2004-02-27
EP0765668A1 (de) 1997-04-02
US6471997B1 (en) 2002-10-29
PL324558A1 (en) 1998-06-08
EP0765668B1 (de) 1999-03-17
ES2132855T3 (es) 1999-08-16
MX9710479A (es) 1998-03-31
JP3093154B2 (ja) 2000-10-03
RU2169000C2 (ru) 2001-06-20
JPH09124499A (ja) 1997-05-13
CA2185037A1 (fr) 1997-03-08
AR003496A1 (es) 1998-08-05

Similar Documents

Publication Publication Date Title
DE69601765T2 (de) Extrakt von Iridaceen und Zusammensetzungen, die ihn enthalten
DE69711640D1 (de) Naphthopyrane, zusammensetzungen und artikel die diese enthalten
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
DE69524451T2 (de) Zementartige, gipsenthaltende zusammensetzungen und hergestellte materialien die diese verwenden
FR2694195B1 (fr) Nouvelles compositions cosmétiques amincissantes.
KR970703779A (ko) 건강 조성물(health composition)
MX9205264A (es) Composiciones oleosas.
DE69007908T2 (de) Shampoo-Zusammensetzung.
SE9802937D0 (sv) Novel compounds
FR2733149B1 (fr) Nouvelles compositions cosmetiques amincissantes
BR9506389B1 (pt) composto de silìcio, e, composição dietética, cosmética e terapêutica.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DE69400752T2 (de) Zusammensetzungen die hexafluorpropan enthalten
FR2735687B1 (fr) Nouvelles compositions cosmetiques amincissantes
TR199501553A2 (tr) Sefem bilesimleri ve bunlarin farmasötik olarak kullanilmasi.
IT1272208B (it) Composizioni pesticide.
TR199601012A2 (tr) Sampuan terkibi.
DE69620013D1 (de) Zusammensetzungen, die modifizierte polyalkadiene enthalten
DE69611414T2 (de) Ribosomenfraktion und Zusammensetzung, die sie enthält
DE69009823T2 (de) Zusammensetzungen, die 2-Thiocyanomethylthiobenzothiazol enthalten.
MX9200566A (es) Composiciones cosmeticas.
DE69509361T2 (de) Polyetherglyole und alkohole aus 3,4-epoxy-1-butenen
NL193317B (nl) 1,8-Diacyloxy-10-acylantronen en cosmetische en farmaceutische samenstellingen die ze bevatten.
DE69006508D1 (de) Azeotropähnliche zusammensetzungen von 1,3-dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.